ESR1 and breast carcinoma: Given the phosphorylation level of ERα-Ser167 was significantly altered when LEM4 was overexpressed or depleted in ER+ breast cancer cells, we then determined whether LEM4 could directly regulate the phosphorylation of ERα–Ser167.